F. Palella, . Jr, R. Baker, and A. Moorman, Mortality in the Highly Active Antiretroviral Therapy Era, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.43, issue.1, pp.27-34, 2006.
DOI : 10.1097/01.qai.0000233310.90484.16

J. Currier, A. Taylor, and F. Boyd, Coronary Heart Disease in HIV-Infected Individuals, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.33, issue.4, pp.506-512, 2003.
DOI : 10.1097/00126334-200308010-00012

M. Saves, G. Chene, and P. Ducimetiere, Risk Factors for Coronary Heart Disease in Patients Treated for Human Immunodeficiency Virus Infection Compared with the General Population, Clinical Infectious Diseases, vol.37, issue.2, pp.292-298, 2003.
DOI : 10.1086/375844

M. Law, N. Friis-moller, and R. Weber, Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) study, HIV Medicine, vol.126, issue.1, pp.1-10, 2003.
DOI : 10.1001/jama.285.19.2486

T. Glass, C. Ungsedhapand, and M. Wolbers, Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study, HIV Medicine, vol.10, issue.1, pp.404-414, 2006.
DOI : 10.1046/j.1468-1293.2003.00138.x

N. Friis-moller, R. Weber, and P. Reiss, Cardiovascular disease risk factors in HIV patients ??? association with antiretroviral therapy. Results from the DAD study, AIDS, vol.17, issue.8, pp.1179-93, 2003.
DOI : 10.1097/00002030-200305230-00010

D. Eisenberg, Cholesterol Lowering in the Management of Coronary Artery Disease: The Clinical Implications of Recent Trials, The American Journal of Medicine, vol.104, issue.2, pp.2-5, 1998.
DOI : 10.1016/S0002-9343(98)00038-2

P. Mercie, R. Thiebaut, and V. Lavignolle, Evaluation of cardiovascular risk factors in HIV-1 infected patients using carotid intima-media thickness measurement, Annals of Medicine, vol.34, issue.1, pp.55-63, 2002.
DOI : 10.1080/078538902317338652

P. Hsue, J. Lo, and A. Franklin, Progression of Atherosclerosis as Assessed by Carotid Intima-Media Thickness in Patients With HIV Infection, Circulation, vol.109, issue.13, pp.1603-1611, 2004.
DOI : 10.1161/01.CIR.0000124480.32233.8A

A. Lebech, N. Wiinberg, and U. Kristoffersen, Carotid intima?media thickness in HIV patients treated with antiretroviral therapy, Clinical Physiology and Functional Imaging, vol.19, issue.3, pp.173-182, 2007.
DOI : 10.1016/0140-6736(92)92270-P

J. Currier, M. Kendall, and H. Wk, Progression of carotid artery intima???media thickening in HIV-infected and uninfected adults, AIDS, vol.21, issue.9, pp.1137-1182, 2007.
DOI : 10.1097/QAD.0b013e32811ebf79

N. Friis-moller, C. Sabin, and R. Weber, Combination antiretroviral therapy and the risk of myocardial infarction, N Engl J Med, vol.349, pp.1993-2003, 2003.

M. Mary-krause, L. Cotte, A. Simon, and M. Partisani, Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men, AIDS, vol.17, issue.17, pp.2479-2486, 2003.
DOI : 10.1097/00002030-200311210-00010

C. Jerico, H. Knobel, and N. Calvo, Subclinical Carotid Atherosclerosis in HIV-Infected Patients: Role of Combination Antiretroviral Therapy, Stroke, vol.37, issue.3, pp.812-819, 2006.
DOI : 10.1161/01.STR.0000204037.26797.7f

B. Coll, S. Parra, and C. Alonso-villaverde, HIV-infected patients with lipodystrophy have higher rates of carotid atherosclerosis: The role of monocyte chemoattractant protein-1, Cytokine, vol.34, issue.1-2, 2006.
DOI : 10.1016/j.cyto.2006.03.013

M. Austin, M. King, K. Vranizan, and R. Krauss, Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk, Circulation, vol.82, issue.2, pp.495-506, 1990.
DOI : 10.1161/01.CIR.82.2.495

R. Thiebaut, V. Daucourt, and M. P. , Lipodystrophy, Metabolic Disorders, and Human Immunodeficiency Virus Infection: Aquitaine Cohort, France, 1999, Clinical Infectious Diseases, vol.31, issue.6, pp.1482-1489, 1999.
DOI : 10.1086/317477

D. Matthews, J. Hosker, and A. Rudenski, Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, vol.92, issue.7, pp.412-419, 1985.
DOI : 10.1007/BF00280883

S. Badiou, M. D. Boever, C. Dupuy, A. Baillat, V. Cristol et al., Decrease in LDL size in HIV-positive adults before and after lopinavir/ritonavir-containing regimen: an index of atherogenicity?, Atherosclerosis, vol.168, issue.1, pp.107-120, 2003.
DOI : 10.1016/S0021-9150(03)00058-3

A. Dupuy, S. Badiou, B. Descomps, and J. Cristol, Immunoturbidimetric Determination of C-Reactive Protein (CRP) and High-Sensitivity CRP on Heparin Plasma. Comparison with Serum Determination, Clinical Chemistry and Laboratory Medicine, vol.41, issue.7, pp.948-957, 2003.
DOI : 10.1515/CCLM.2003.144

V. Witko-sarsat, M. Friedlander, N. Khoa, and T. , Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure, J Immunol, vol.161, pp.2524-2556, 1998.

K. Yaggi, A simple fluorometric assay for lipoperoxide in blood plasma, Biochemical Medicine, vol.15, issue.2, pp.212-216, 1976.
DOI : 10.1016/0006-2944(76)90049-1

S. Schwedler, T. Metzger, R. Schinzel, and C. Wanner, Advanced glycation end products and mortality in hemodialysis patients, Kidney International, vol.62, issue.1, pp.301-311, 2002.
DOI : 10.1046/j.1523-1755.2002.00423.x

C. Saely, P. Rein, and H. Drexel, The Metabolic Syndrome and Risk of Cardiovascular Disease and Diabetes: Experiences with the New Diagnostic Criteria from the International Diabetes Federation, Hormone and Metabolic Research, vol.39, issue.9, pp.642-50, 2007.
DOI : 10.1055/s-2007-985822

A. Sandhofer, B. Iglseder, B. Paulweber, C. Ebenbichler, and J. Patsch, Comparison of different definitions of the metabolic syndrome, European Journal of Clinical Investigation, vol.23, issue.2, pp.109-125, 2007.
DOI : 10.1001/jama.283.2.221

A. Mangili, D. Jacobson, J. Gerrior, J. Polak, S. Gorbach et al., Metabolic Syndrome and Subclinical Atherosclerosis in Patients Infected with HIV, Clinical Infectious Diseases, vol.44, issue.10, pp.1368-74, 2007.
DOI : 10.1086/516616

S. Johnsen, S. Dolan, and K. Fitch, Carotid Intimal Medial Thickness in Human Immunodeficiency Virus-Infected Women: Effects of Protease Inhibitor Use, Cardiac Risk Factors, and the Metabolic Syndrome, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.12, pp.4916-4940, 2006.
DOI : 10.1210/jc.2006-1140

K. Samaras, H. Wand, M. Law, S. Emery, D. Cooper et al., Prevalence of Metabolic Syndrome in HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy Using International Diabetes Foundation and Adult Treatment Panel III Criteria: Associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and hypoadiponectinemia, Diabetes Care, vol.30, issue.1, pp.113-122, 2007.
DOI : 10.2337/dc06-1075

C. Jerico, H. Knobel, and M. Montero, Metabolic Syndrome Among HIV-Infected Patients: Prevalence, characteristics, and related factors, Diabetes Care, vol.28, issue.1, pp.132-139, 2005.
DOI : 10.2337/diacare.28.1.132

D. Jacobson, A. Tang, and D. Spiegelman, Incidence of Metabolic Syndrome in a Cohort of HIV-Infected Adults and Prevalence Relative to the US Population (National Health and Nutrition Examination Survey), JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.43, issue.4, pp.458-66, 2006.
DOI : 10.1097/01.qai.0000243093.34652.41

B. Pannier, F. Thomas, and E. Eschwege, Cardiovascular risk markers associated with the metabolic syndrome in a large French population: the SYMFONIE study, Diabetes & Metabolism, vol.32, issue.5, pp.467-7410, 2006.
DOI : 10.1016/S1262-3636(07)70305-1

M. Rutter, J. Meigs, L. Sullivan, D. Agostino, R. Sr et al., C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring Study, Circulation, vol.110, issue.4, pp.380-385, 2004.
DOI : 10.1161/01.CIR.0000136581.59584.0E

B. Hansel, P. Giral, and E. Nobecourt, Metabolic Syndrome Is Associated with Elevated Oxidative Stress and Dysfunctional Dense High-Density Lipoprotein Particles Displaying Impaired Antioxidative Activity, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.10, pp.4963-71, 2004.
DOI : 10.1210/jc.2004-0305

P. Mercie, R. Thiebaut, and V. Aurillac-lavignolle, Carotid intima-media thickness is slightly increased over time in HIV-1-infected patients*, HIV Medicine, vol.8, issue.6, pp.380-387, 2005.
DOI : 10.1038/35393

R. Thiebaut, V. Aurillac-lavignolle, and F. Bonnet, Change in atherosclerosis progression in HIV-infected patients: ANRS Aquitaine Cohort, 1999???2004, AIDS, vol.19, issue.7, pp.729-760, 1999.
DOI : 10.1097/01.aids.0000166097.46940.35